Demo
Breast-001 Study
An Oncology Clinical Study for neoTrial System Demonstration Purposes with Demo-Drug-001 as Monotherapy in Fictional Patients with Metastatic Breast Cancer (MBC)
IBD-321-001 Study
A Phase 2, randomized, double-blind, placebo-controlled, multi-center study to evaluate bi-weekly subcutaneous self-injection IBD-321 in adult subjects with active ulcerative colitis